Thy-1+ Cancer-associated Fibroblasts Adversely Impact Lung Cancer Prognosis.
Saved in:
| Title: | Thy-1+ Cancer-associated Fibroblasts Adversely Impact Lung Cancer Prognosis. |
|---|---|
| Authors: | Schliekelman MJ; Division of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, Washington, United States of America., Creighton CJ; Department of Medicine and Dan L. Duncan Cancer Center, Baylor College of Medicine, Houston, Texas, United States of America.; Department of Bioinformatics and Computational Biology, University of Texas MD Anderson Cancer Center, Houston, Texas, United States of America., Baird BN; Department of Thoracic/Head and Neck Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, Texas, United States of America., Chen Y; Department of Thoracic/Head and Neck Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, Texas, United States of America., Banerjee P; Department of Thoracic/Head and Neck Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, Texas, United States of America., Bota-Rabassedas N; Department of Thoracic/Head and Neck Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, Texas, United States of America., Ahn YH; Department of Thoracic/Head and Neck Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, Texas, United States of America.; Department of Molecular Medicine and Tissue Injury Defense Research Center, Ewha Womans University School of Medicine, Seoul, Korea., Roybal JD; Department of Thoracic/Head and Neck Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, Texas, United States of America., Chen F; Department of Medicine and Dan L. Duncan Cancer Center, Baylor College of Medicine, Houston, Texas, United States of America., Zhang Y; Department of Medicine and Dan L. Duncan Cancer Center, Baylor College of Medicine, Houston, Texas, United States of America., Mishra DK; Department of Surgery, Houston Methodist Research Institute, Houston, Texas, United States of America., Kim MP; Department of Surgery, Houston Methodist Research Institute, Houston, Texas, United States of America., Liu X; Department of Thoracic/Head and Neck Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, Texas, United States of America., Mino B; Department of Translational Molecular Pathology, University of Texas MD Anderson Cancer Center, Houston, Texas, United States of America., Villalobos P; Department of Translational Molecular Pathology, University of Texas MD Anderson Cancer Center, Houston, Texas, United States of America., Rodriguez-Canales J; Department of Translational Molecular Pathology, University of Texas MD Anderson Cancer Center, Houston, Texas, United States of America., Behrens C; Department of Translational Molecular Pathology, University of Texas MD Anderson Cancer Center, Houston, Texas, United States of America., Wistuba II; Department of Translational Molecular Pathology, University of Texas MD Anderson Cancer Center, Houston, Texas, United States of America., Hanash SM; Division of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, Washington, United States of America.; Department of Clinical Cancer Prevention, University of Texas MD Anderson Cancer Center, Houston, Texas, United States of America., Kurie JM; Department of Thoracic/Head and Neck Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, Texas, United States of America. jkurie@mdanderson.org. |
| Source: | Scientific reports [Sci Rep] 2017 Jul 25; Vol. 7 (1), pp. 6478. Date of Electronic Publication: 2017 Jul 25. |
| Publication Type: | Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S. |
| Journal Info: | Publisher: Nature Publishing Group Country of Publication: England NLM ID: 101563288 Publication Model: Electronic Cited Medium: Internet ISSN: 2045-2322 (Electronic) Linking ISSN: 20452322 NLM ISO Abbreviation: Sci Rep Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 28744021 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Thy-1<superscript>+</superscript> Cancer-associated Fibroblasts Adversely Impact Lung Cancer Prognosis. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Schliekelman+MJ%22">Schliekelman MJ</searchLink>; Division of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, Washington, United States of America.<br /><searchLink fieldCode="AU" term="%22Creighton+CJ%22">Creighton CJ</searchLink>; Department of Medicine and Dan L. Duncan Cancer Center, Baylor College of Medicine, Houston, Texas, United States of America.; Department of Bioinformatics and Computational Biology, University of Texas MD Anderson Cancer Center, Houston, Texas, United States of America.<br /><searchLink fieldCode="AU" term="%22Baird+BN%22">Baird BN</searchLink>; Department of Thoracic/Head and Neck Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, Texas, United States of America.<br /><searchLink fieldCode="AU" term="%22Chen+Y%22">Chen Y</searchLink>; Department of Thoracic/Head and Neck Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, Texas, United States of America.<br /><searchLink fieldCode="AU" term="%22Banerjee+P%22">Banerjee P</searchLink>; Department of Thoracic/Head and Neck Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, Texas, United States of America.<br /><searchLink fieldCode="AU" term="%22Bota-Rabassedas+N%22">Bota-Rabassedas N</searchLink>; Department of Thoracic/Head and Neck Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, Texas, United States of America.<br /><searchLink fieldCode="AU" term="%22Ahn+YH%22">Ahn YH</searchLink>; Department of Thoracic/Head and Neck Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, Texas, United States of America.; Department of Molecular Medicine and Tissue Injury Defense Research Center, Ewha Womans University School of Medicine, Seoul, Korea.<br /><searchLink fieldCode="AU" term="%22Roybal+JD%22">Roybal JD</searchLink>; Department of Thoracic/Head and Neck Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, Texas, United States of America.<br /><searchLink fieldCode="AU" term="%22Chen+F%22">Chen F</searchLink>; Department of Medicine and Dan L. Duncan Cancer Center, Baylor College of Medicine, Houston, Texas, United States of America.<br /><searchLink fieldCode="AU" term="%22Zhang+Y%22">Zhang Y</searchLink>; Department of Medicine and Dan L. Duncan Cancer Center, Baylor College of Medicine, Houston, Texas, United States of America.<br /><searchLink fieldCode="AU" term="%22Mishra+DK%22">Mishra DK</searchLink>; Department of Surgery, Houston Methodist Research Institute, Houston, Texas, United States of America.<br /><searchLink fieldCode="AU" term="%22Kim+MP%22">Kim MP</searchLink>; Department of Surgery, Houston Methodist Research Institute, Houston, Texas, United States of America.<br /><searchLink fieldCode="AU" term="%22Liu+X%22">Liu X</searchLink>; Department of Thoracic/Head and Neck Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, Texas, United States of America.<br /><searchLink fieldCode="AU" term="%22Mino+B%22">Mino B</searchLink>; Department of Translational Molecular Pathology, University of Texas MD Anderson Cancer Center, Houston, Texas, United States of America.<br /><searchLink fieldCode="AU" term="%22Villalobos+P%22">Villalobos P</searchLink>; Department of Translational Molecular Pathology, University of Texas MD Anderson Cancer Center, Houston, Texas, United States of America.<br /><searchLink fieldCode="AU" term="%22Rodriguez-Canales+J%22">Rodriguez-Canales J</searchLink>; Department of Translational Molecular Pathology, University of Texas MD Anderson Cancer Center, Houston, Texas, United States of America.<br /><searchLink fieldCode="AU" term="%22Behrens+C%22">Behrens C</searchLink>; Department of Translational Molecular Pathology, University of Texas MD Anderson Cancer Center, Houston, Texas, United States of America.<br /><searchLink fieldCode="AU" term="%22Wistuba+II%22">Wistuba II</searchLink>; Department of Translational Molecular Pathology, University of Texas MD Anderson Cancer Center, Houston, Texas, United States of America.<br /><searchLink fieldCode="AU" term="%22Hanash+SM%22">Hanash SM</searchLink>; Division of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, Washington, United States of America.; Department of Clinical Cancer Prevention, University of Texas MD Anderson Cancer Center, Houston, Texas, United States of America.<br /><searchLink fieldCode="AU" term="%22Kurie+JM%22">Kurie JM</searchLink>; Department of Thoracic/Head and Neck Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, Texas, United States of America. jkurie@mdanderson.org. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101563288%22">Scientific reports</searchLink> [Sci Rep] 2017 Jul 25; Vol. 7 (1), pp. 6478. <i>Date of Electronic Publication: </i>2017 Jul 25. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S. – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Nature+Publishing+Group%22">Nature Publishing Group </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>101563288 <i>Publication Model: </i>Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>2045-2322 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2220452322%22">20452322 </searchLink><i>NLM ISO Abbreviation: </i>Sci Rep <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=28744021 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1038/s41598-017-06922-5 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 6478 Titles: – TitleFull: Thy-1+ Cancer-associated Fibroblasts Adversely Impact Lung Cancer Prognosis. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Schliekelman MJ – PersonEntity: Name: NameFull: Creighton CJ – PersonEntity: Name: NameFull: Baird BN – PersonEntity: Name: NameFull: Chen Y – PersonEntity: Name: NameFull: Banerjee P – PersonEntity: Name: NameFull: Bota-Rabassedas N – PersonEntity: Name: NameFull: Ahn YH – PersonEntity: Name: NameFull: Roybal JD – PersonEntity: Name: NameFull: Chen F – PersonEntity: Name: NameFull: Zhang Y – PersonEntity: Name: NameFull: Mishra DK – PersonEntity: Name: NameFull: Kim MP – PersonEntity: Name: NameFull: Liu X – PersonEntity: Name: NameFull: Mino B – PersonEntity: Name: NameFull: Villalobos P – PersonEntity: Name: NameFull: Rodriguez-Canales J – PersonEntity: Name: NameFull: Behrens C – PersonEntity: Name: NameFull: Wistuba II – PersonEntity: Name: NameFull: Hanash SM – PersonEntity: Name: NameFull: Kurie JM IsPartOfRelationships: – BibEntity: Dates: – D: 25 M: 07 Text: 2017 Jul 25 Type: published Y: 2017 Identifiers: – Type: issn-electronic Value: 2045-2322 Numbering: – Type: volume Value: 7 – Type: issue Value: 1 Titles: – TitleFull: Scientific reports Type: main |
| ResultId | 1 |